title: Cheaper alternative for macular degeneration is as safe as licensed drug, review finds.
authors.affiliation: The BMJ.
authors.forename: Zosia
authors.initials: Z
authors.lastname: Kmietowicz
mesh_terms: D020533:Angiogenesis Inhibitors / Q000009:adverse effects* / Q000191:economics; D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects* / Q000191:economics; D000068258:Bevacizumab; D006801:Humans; D000069579:Ranibizumab; D057135:Wet Macular Degeneration / Q000188:drug therapy*
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D000069579:Ranibizumab